Leo Pharma consolidates global commercial organization, reducing overall unit count
In an attempt to streamline and build a more competitive organization, the Danish dermatology firm has merged a number of international commercial divisions.
by ulrich quistgaard, translated by daniel pedersen
After holding meetings around the world, Leo Pharma can now announce that a number of the firm’s international sales units have been consolidated, the firm reports in a press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Leo Pharma poaches Novo Nordisk VP to lead US division
For subscribers
.jpg&w=384&q=75)
